University Hospitals Birmingham NHS Foundation Trust

Medicines A–Z

C

Status Drug name NICE TAs Comments
Status: Green Carbamazepine suppositories

Tegretol

Status: Green Carbamazepine tablets

Tegretol

Status: Green Carbimazole tablets

Neutropenia and agranulocytosis. Doctors are reminded of the importance of recognising bone marrow suppression induced by carbimazole and the need to stop treatment promptly. Patient should be asked to report symptoms and signs suggestive of infection, especially sore throat. A white blood cell count should be performed if there is any clinical evidence of infection. Carbimazole should be stopped promptly if there is clinical or laboratory evidence of neutropenia. 

Status: Green Carbocisteine
Status: Red Carboplatin injection
Status: Red Carboprost
Status: Red Carfilzomib

For hospital use only

Status: Red Carfilzomib (Kyprolis®)
Status: Red Carglumic acid

NHSE commissioned

Status: Red Carglumic acid dispersible tablets

NHSE commissioned.

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top